Gene · 2017
Papers4,431
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 4,431
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Chromosome-level Dinobdella ferox genome provided a molecular model for its specific parasitism. | Parasit Vectors | 2023 | 37697397 | PubTator, text mining | PubMed |
| Potential Biomarkers Associated with Prognosis and Trastuzumab Response in HER2+ Breast Cancer. | Cancers (Basel) | 2023 | 37686651 | PubTator, text mining | PubMed |
| Lymph Node Metastases from Non-Melanoma Skin Cancer of the Head and Neck. | Cancers (Basel) | 2023 | 37686478 | PubTator, text mining | PubMed |
| THBS1-Mediated Degradation of Collagen via the PI3K/AKT Pathway Facilitates the Metastasis and Poor Prognosis of OSCC. | Int J Mol Sci | 2023 | 37686118 | PubTator, text mining | PubMed |
| Biological Liquid-Liquid Phase Separation, Biomolecular Condensates, and Membraneless Organelles: Now You See Me, Now You Don't. | Int J Mol Sci | 2023 | 37685957 | PubTator, text mining | PubMed |
| Human Papillomavirus-Associated Tumor Extracellular Vesicles in HPV+ Tumor Microenvironments. | J Clin Med | 2023 | 37685735 | PubTator, text mining | PubMed |
| Identification of a new anoikis-related gene signature for prognostic significance in head and neck squamous carcinomas. | Medicine (Baltimore) | 2023 | 37682196 | PubTator, text mining | PubMed |
| Targeting reversible post-translational modifications with PROTACs: a focus on enzymes modifying protein lysine and arginine residues. | J Enzyme Inhib Med Chem | 2023 | 37667522 | PubTator, text mining | PubMed |
| DAB2IP suppresses invadopodia formation through destabilizing ALK by interacting with USP10 in breast cancer. | iScience | 2023 | 37664607 | PubTator, text mining | PubMed |
| Targeted splicing therapy: new strategies for colorectal cancer. | Front Oncol | 2023 | 37664052 | PubTator, text mining | PubMed |
| The immune suppressive properties of damage associated molecular patterns in the setting of sterile traumatic injury. | Front Immunol | 2023 | 37662933 | PubTator, text mining | PubMed |
| Histone deacetylase 6's function in viral infection, innate immunity, and disease: latest advances. | Front Immunol | 2023 | 37638049 | PubTator, text mining | PubMed |
| A novel 3D biofabrication strategy to improve cell proliferation and differentiation of human Wharton's jelly mesenchymal stromal cells for cell therapy and tissue engineering. | Front Bioeng Biotechnol | 2023 | 37636000 | PubTator, text mining | PubMed |
| The Molecular Regulatory Mechanism in Multipotency and Differentiation of Wharton's Jelly Stem Cells. | Int J Mol Sci | 2023 | 37629090 | PubTator, text mining | PubMed |
| The Proteome Profile of Olfactory Ecto-Mesenchymal Stem Cells-Derived from Patients with Familial Alzheimer's Disease Reveals New Insights for AD Study. | Int J Mol Sci | 2023 | 37628788 | PubTator, text mining | PubMed |
| A Systematic Compilation of Human SH3 Domains: A Versatile Superfamily in Cellular Signaling. | Cells | 2023 | 37626864 | PubTator, text mining | PubMed |
| The Role of c-Abl Tyrosine Kinase in Brain and Its Pathologies. | Cells | 2023 | 37626851 | PubTator, text mining | PubMed |
| Co-Targeting Nucleus Accumbens Associate 1 and NF-κB Signaling Synergistically Inhibits Melanoma Growth. | Biomedicines | 2023 | 37626718 | PubTator, text mining | PubMed |
| A Prospective Observational Study on the Role of Immunohistochemical Expression of Orphanin in Laryngeal Squamous Cell Carcinoma Recurrence. | J Pers Med | 2023 | 37623462 | PubTator, text mining | PubMed |
| Analysis of Genes Related to Invadopodia Formation and CTTN in Oral Squamous Cell Carcinoma-A Systematic Gene Expression Analysis. | Curr Issues Mol Biol | 2023 | 37623256 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2017/papers?page=13